Related Experiment Video
Updated: Jul 3, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Determinants of Infant Participation and Non-Participation in Primary Prevention Trials
Franziska Wörl1,2,3, Peter Achenbach3,4,5, Ezio Bonifacio6,7,8
1Ludwig-Maximilians-Universität München, Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), Chair of Public Health and Health Service Research, LMU Medizin, Germany, Munich.
Insights
Parental decisions to enroll infants in type 1 diabetes prevention trials are influenced by factors like family history and maternal age. Understanding these determinants improves trial participation and generalizability for autoimmune diabetes research.
Area of Science:
- Clinical Trials
- Pediatric Autoimmunity
- Diabetes Prevention
Background:
- Representative samples are crucial for generalizability in infant prevention trials.
- Understanding parental decision-making is key to improving recruitment and outcomes.
Purpose of the Study:
- To identify determinants of parental participation in infant primary prevention trials for autoimmune diabetes.
- To analyze factors influencing enrollment in the Primary Oral Insulin Trial and the Supplementation with B. INfantis for Mitigation of Type 1 Diabetes Autoimmunity Trial.
Main Methods:
- Quantitative and qualitative data analysis from over 6,000 infants across two global prevention trials.
- Statistical analysis of demographic, familial, and logistical factors affecting participation.
- Thematic analysis of qualitative data from 638 families regarding perceived risk and participation burden.
Main Results:
- Longer decision time, family history of type 1 diabetes, and higher maternal age increased participation likelihood.
- Infants born in fall and those with longer travel distances to study centers were less likely to participate.
- Participation varied between trials, with factors like the COVID-19 pandemic impacting recruitment differently.
Conclusions:
- Key determinants for participation in infant prevention trials include family history, maternal age, and logistical factors.
- Parental perception of risk and the perceived burden of participation significantly influence enrollment decisions.
- Study-specific factors and trial design impact participation, necessitating tailored recruitment strategies for autoimmune diabetes research.
Abstract:
Understanding the determinants that influence parents' decisions to participate with their infants in primary prevention trials is essential for achieving representative study samples and ensuring the generalizability of outcomes. We analyzed quantitative and qualitative data collected from infants eligible for the Primary Oral Insulin Trial (N=2,750) or the Supplementation with B. INfantis for Mitigation of Type 1 Diabetes Autoimmunity Trial (N=3,309). Both trials were conducted within the Global Platform for the Prevention of Autoimmune Diabetes between 07/2017 and 04/2024. Among all eligible infants, a longer decision time (odds ratio: 1.01, 95% confidence interval: 1.00-1.01, and p=0.002), having a first-degree relative with type 1 diabetes (odds ratio: 2.18, 95% confidence interval: 1.95-2.43, and p<0.001), and a higher maternal age (odds ratio: 1.03, 95% confidence interval: 1.01-1.05, and p=0.003) were associated with a higher likelihood of participation, whereas infants born in fall (odds ratio: 0.85, 95% confidence interval: 0.73-0.98, and p=0.03) and families with longer travel distances to the study center (odds ratio: 0.97, 95% confidence interval: 0.95-0.99, and p=0.01) were less likely to participate. Participation was lower in the Supplementation with B. INfantis for Mitigation of Type 1 Diabetes Autoimmunity Trial than in the Primary Oral Insulin Trial (odds ratio: 0.86, 95% confidence interval: 0.78-0.96, and p=0.005), and stratified analyses indicated that some factors, such as recruitment during the COVID-19 pandemic, affected participation differently between studies. Analysis of qualitative data from 638 families identified additional factors, including the parental perception of the child's risk for type 1 diabetes and the burden of participation. In conclusion, this study identifies both general and study-specific determinants and reasons of participation and non-participation in infant primary prevention trials.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
What is an Experiment?
Preventive Healthcare Services
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Bias in Epidemiological Studies
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...